Back to search
FDAFDA · Food and drugs·Recall number D-0365-2024

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60

Published March 13, 2024 · Recall initiated: February 20, 2024

Summary

FDA records drug Class III recall D-0365-2024, published March 13, 2024 and initiated February 20, 2024. Recalling firm: Contract Pharmaceuticals Limited Canada; Status: Ongoing; Reported quantity: 11,750 bottles; Lot: Lot #: 119874; Exp 06/30/2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Contract Pharmaceuticals Limited Canada
Distributor
Nationwide in the U.S. and Puerto Rico
Lot
Lot #: 119874; Exp 06/30/2025
Risk classification
Class III
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60 recalled?

Yes. FDA published recall D-0365-2024 on March 13, 2024. Reported hazard: Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

What should I do if I have this product?

Voluntary: Firm initiated · Letter